ERBB2 and breast cancer: The PI3KCA mutations were prevalent in luminal B (HER2–) (40%) and luminal A subtypes (36%) in Chinese patients, while the proportions of these two subtypes in the FUSCC‐BC cohort were lower than those in the MSKCC cohort (Figure 1A, B).